HomeONCY • NASDAQ
add
Oncolytics Biotech Inc
$1.01
Makalipas ang Oras ng Trabaho:(2.05%)-0.021
$0.99
Sarado: Ago 22, 8:00:00 PM GMT-4 · USD · NASDAQ · Disclaimer
Nakaraang pagsara
$1.01
Sakop ng araw
$0.99 - $1.05
Sakop ng taon
$0.33 - $1.53
Market cap
88.76M USD
Average na Volume
867.83K
P/E ratio
-
Dividend yield
-
Sa balita
Mga Financial
Income Statement
Kita
Net na kita
| (CAD) | Hun 2025info | Y/Y na pagbabago |
|---|---|---|
Kita | — | — |
Gastos sa pagpapatakbo | 5.71M | -27.95% |
Net na kita | -6.16M | 15.04% |
Net profit margin | — | — |
Kita sa bawat share | -0.07 | 28.86% |
EBITDA | -5.68M | 28.02% |
Aktuwal na % ng binabayarang buwis | -1.40% | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (CAD) | Hun 2025info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 14.63M | -41.14% |
Kabuuang asset | 19.97M | -37.72% |
Kabuuang sagutin | 13.88M | 0.92% |
Kabuuang equity | 6.09M | — |
Natitirang share | 100.36M | — |
Presyo para makapag-book | 16.83 | — |
Return on assets | -71.91% | — |
Return on capital | -197.15% | — |
Cash Flow
Net change in cash
| (CAD) | Hun 2025info | Y/Y na pagbabago |
|---|---|---|
Net na kita | -6.16M | 15.04% |
Cash mula sa mga operasyon | -5.47M | 19.77% |
Cash mula sa pag-invest | — | — |
Cash mula sa financing | 5.37M | 172.05% |
Net change in cash | -677.00K | 85.76% |
Malayang cash flow | -3.25M | 28.13% |
Tungkol
Oncolytics Biotech Inc. is a Canadian company headquartered in Calgary, Alberta, that is developing an intravenously delivered immuno-oncolytic virus called pelareorep for the treatment of solid tumors and hematological malignancies. Pelareorep is a non-pathogenic, proprietary isolate of the unmodified reovirus that: induces selective tumor lysis and promotes an inflamed tumor phenotype through innate and adaptive immune responses. Wikipedia
Itinatag
1998
Headquarters
Website
Mga Empleyado
28
